Senate HELP Innovate-A-Palooza

Politico, March 9, 2016. The National Center for Health Research is concerned that the Innovation Act, including the MEDTECH bill, will endanger patient safety by reducing FDA oversight.

Read More »

PhRMA: Easing Speech Limits Could Reduce Need for Subgroups in Trials

InsideHealthPolicy.com, March 7, 2016. While minority, patient and consumer groups pushed for more diversity in the clinical trial phase, Jocelyn Ulrich director of scientific and regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said matching demographic subgroups based on sex, age and race, specifically the African American and Hispanic populations, to disease prevalence would extend phase III clinical trials by 20 months or longer.

Read More »

Remedy for a Sick Industry

Portland Tribune, March 3, 2016. If he were playing it safe, Dr. Vinay Prasad might be among the last to turn into a medical provocateur. Prasad’s outspokenness and willingness to criticize industrywide assumptions place him in the ranks of a small but influential group of physicians and researchers who are either having an impact on the way medicine is practiced in the United States, or tilting at windmills.

Read More »